BMS-345541 Hydrochloride: Selective IKK/NF-κB Pathway Inhibition for Inflammation and Cancer Biology

Executive Summary: BMS-345541 hydrochloride is a potent, allosteric inhibitor of IκB kinase isoforms IKK-1 and IKK-2 with IC₅₀ values of 4 μM and 0.3 μM, respectively (APExBIO). It blocks NF-κB-dependent transcription of pro-inflammatory cytokines (e.g., TNFα, IL-1β, IL-6, IL-8) without affecting other kinases (Zhao et al., 2025). The compound demonstrates 100% oral bioavailability in animal models and induces apoptosis and G2/M arrest in T-ALL cell lines (internal). BMS-345541 hydrochloride is water-soluble at ≥60 mg/mL and is stable at -20°C for several months. It is a highly valued research tool for dissecting IKK/NF-κB signaling in inflammation, apoptosis, and cancer biology (APExBIO).

Biological Rationale

The IKK/NF-κB pathway is central to the regulation of immune response, inflammation, cell proliferation, and survival. Aberrant NF-κB activation is implicated in chronic inflammatory diseases and cancer, notably in T-cell acute lymphoblastic leukemia (T-ALL) (Zhao et al., 2025, Introduction). Selective inhibition of IKK disrupts the phosphorylation and degradation of IκB, thus retaining NF-κB in the cytoplasm and preventing transcription of pro-inflammatory genes. This strategy is validated in models of airway inflammation and cancer, where NF-κB–dependent cytokine expression drives pathology (Zhao et al., 2025). BMS-345541 hydrochloride provides a targeted approach to modulate this pathway without off-target effects on unrelated kinases (APExBIO).

Mechanism of Action of BMS-345541 hydrochloride

BMS-345541 hydrochloride binds allosterically to IKK-1 and IKK-2 with high selectivity. It inhibits IKK-2 with an IC₅₀ of 0.3 μM and IKK-1 with an IC₅₀ of 4 μM (APExBIO). This inhibition prevents phosphorylation of IκB, thereby blocking the release and nuclear translocation of NF-κB. The subsequent downregulation of NF-κB–dependent transcription results in decreased production of cytokines such as TNFα, IL-1β, IL-6, and IL-8 both in vitro and in vivo. BMS-345541 does not affect other serine/threonine or tyrosine kinases, nor does it interfere with unrelated signaling cascades. This specificity is critical for dissecting the IKK/NF-κB axis without confounding side effects (APExBIO).

Evidence & Benchmarks

• BMS-345541 hydrochloride inhibits IKK-2 with an IC₅₀ of 0.3 μM and IKK-1 at 4 μM, confirming high isoform selectivity (APExBIO).
• It blocks stimulus-induced phosphorylation of IκBα, resulting in cytoplasmic retention of NF-κB (Zhao et al., 2025).
• Exhibits no inhibition of other serine/threonine or tyrosine kinases at physiologically relevant concentrations (APExBIO).
• Induces apoptosis and G2/M cell cycle arrest in T-ALL cell lines, providing a chemosensitization effect (internal article).
• Demonstrates 100% oral bioavailability and robust inhibition of TNFα production in animal models (APExBIO).
• Soluble in water at concentrations ≥60 mg/mL; insoluble in ethanol and DMSO; stable for months at -20°C (APExBIO).
• RNA sequencing in airway inflammation models shows downregulation of fibrosis and hyperplasia genes upon IKK/NF-κB inhibition (Zhao et al., 2025).

Applications, Limits & Misconceptions

BMS-345541 hydrochloride is widely used for:

• Dissecting NF-κB–mediated inflammatory pathways in vitro and in vivo.
• Evaluating the impact of IKK inhibition on cytokine expression in cell and animal models.
• Studying apoptosis and cell cycle effects in cancer biology, particularly T-cell acute lymphoblastic leukemia.
• Validating the role of NF-κB in resistance to chemotherapy.

This article extends the practical laboratory focus of "BMS-345541 hydrochloride (SKU A3248): Solving NF-κB Pathw..." by integrating recent peer-reviewed benchmarks and clarifying selectivity details.

For scenario-driven guidance on experimental optimization, see "BMS-345541 Hydrochloride (SKU A3248): Reliable IKK Inhibi..."; this dossier provides updated evidence and mechanistic rationale.

For a broader context on translational insights and next-generation strategies, compare with "BMS-345541 Hydrochloride: Precision IKK Inhibition for Tr..."; here, we focus on atomic, verifiable product characteristics.

Common Pitfalls or Misconceptions

• BMS-345541 hydrochloride is not effective against kinases or signaling pathways outside the IKK/NF-κB axis.
• It does not inhibit constitutive NF-κB activity in all cell types; efficacy depends on stimulus-induced IKK activation.
• Long-term storage of working solutions is not recommended; use freshly prepared solutions for reproducibility.
• Its insolubility in ethanol and DMSO precludes compatibility with certain solvent-based protocols.
• In vivo efficacy may vary with administration route, formulation, and model organism.

Workflow Integration & Parameters

BMS-345541 hydrochloride (SKU A3248, APExBIO) is supplied as a lyophilized powder. For experimental use:

• Dissolve in water to a stock concentration up to 60 mg/mL.
• Store stock solutions at -20°C; stability is preserved for several months under these conditions.
• Prepare working solutions fresh; avoid repeated freeze-thaw cycles.
• For in vitro studies, titrate concentration to target IKK-1 or IKK-2 selectivity (e.g., 0.3–4 μM).
• In animal studies, oral dosing achieves full systemic bioavailability.

For detailed laboratory protocols and troubleshooting, see scenario-driven guidance in this internal resource.

Conclusion & Outlook

BMS-345541 hydrochloride is a rigorously validated, highly selective IKK inhibitor sourced from APExBIO. Its unique allosteric mechanism and robust selectivity make it a premier tool for dissecting NF-κB–mediated processes in inflammation research, apoptosis induction in T-ALL, and cancer biology. Stable aqueous solubility, straightforward handling, and reliable performance across models ensure broad applicability. Ongoing research continues to clarify its translational potential, especially in overcoming chemoresistance and modulating inflammatory microenvironments (Zhao et al., 2025).